Toshikazu Tanaka

Papers

Total Citations

H-Index

About

Dr. Toshikazu Tanaka is a leading urologic oncologist whose research focuses on optimizing treatment strategies for prostate cancer, particularly in elderly and high-risk patient populations. His most impactful work centers on the application of the Geriatric 8 (G8) screening tool to assess frailty in prostate cancer patients, a study that has garnered 40 citations and demonstrated how frailty assessment can guide treatment decisions across disease stages. This contribution is pivotal in personalizing care for older adults, helping to balance oncologic efficacy with quality of life. Additionally, Dr. Tanaka has advanced the field of surgical oncology through his investigation of neoadjuvant chemohormonal therapy followed by robot-assisted radical prostatectomy in high-risk patients, a study with 13 citations that compared perioperative and oncological outcomes. His work bridges the gap between aggressive multimodal therapy and minimally invasive surgical techniques, offering insights into safer, more effective treatment pathways. With a career dedicated to improving outcomes through tailored interventions, Dr. Tanaka’s research continues to influence clinical practice in geriatric oncology and surgical urology.